{"nct_id":"NCT06128044","title":"CRISPR-Edited Allogeneic Anti-CLL-1 CAR-T Cell Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia","status":"TERMINATED","status_verified_date":"2025-05","start_date":"2024-02-08","start_date_type":"ACTUAL","primary_completion_date":"2025-05-30","primary_completion_date_type":"ACTUAL","completion_date":"2025-05-30","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["CRBU"]}